ATI Physical Therapy:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ATI Physical Therapy - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10853
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ATI Physical Therapy (ATI) is a healthcare service provider that offers therapy and healthcare services. The center offers therapy services such as hand therapy, women’s health, workers’ comp rehab, sports therapy, physical therapy, specialty therapies, home health and complimentary injury screening services. Its workers’ comp rehab services comprise treatment for increase strength, endurance and cardio function; conducts functional capacity evaluations and earned international recognition for our outcomes and results. ATI offers development of women health that include reduce pelvic floor pain, weakness and dysfunction; manage prenatal and postpartum pain; address incontinence issues, and surgery recovery services. The company offers its services across the US. ATI is headquartered in Bolingbrook, Illinois, the US.

ATI Physical Therapy – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATI Physical Therapy, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deal Details 9
Acquisition 9
ATI Physical Therapy Acquires Matt Smith Physical Therapy 9
ATI Physical Therapy Acquires North River Physical Therapy 10
ATI Physical Therapy Acquires Michigan Rehabilitation Specialists 11
ATI Physical Therapy Acquires SCP Physical Therapy 12
ATI Physical Therapy Acquires MX Physical Therapy 13
ATI Physical Therapy – Key Competitors 14
ATI Physical Therapy – Key Employees 15
ATI Physical Therapy – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Strategy And Business Planning 18
Mar 21, 2017: ATI Physical Therapy Expands Presence in Livonia, MI 18
Feb 13, 2017: ATI Opens Clinic in Ahwatukee 19
Feb 13, 2017: ATI Opens New Clinic in Frisco, TX 20
Jan 17, 2017: ATI Opens New Bellevue – Crossroads Clinic in Washington 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
ATI Physical Therapy, Pharmaceuticals & Healthcare, Key Facts 2
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATI Physical Therapy, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
ATI Physical Therapy Acquires Matt Smith Physical Therapy 9
ATI Physical Therapy Acquires North River Physical Therapy 10
ATI Physical Therapy Acquires Michigan Rehabilitation Specialists 11
ATI Physical Therapy Acquires SCP Physical Therapy 12
ATI Physical Therapy Acquires MX Physical Therapy 13
ATI Physical Therapy, Key Competitors 14
ATI Physical Therapy, Key Employees 15
ATI Physical Therapy, Other Locations 16
ATI Physical Therapy, Subsidiaries 17

List of Figures
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ATI Physical Therapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[ATI Physical Therapy:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vulcan Materials Company:企業の戦略・SWOT・財務情報
    Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report Summary Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Aequus Pharmaceuticals Inc (AQS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …
  • Nufarm Limited (NUF):企業の財務・戦略的SWOT分析
    Nufarm Limited (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • DIRECT Pojistovna, a.s.:企業の戦略・SWOT・財務分析
    DIRECT Pojistovna, a.s. - Strategy, SWOT and Corporate Finance Report Summary DIRECT Pojistovna, a.s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kesko Corporation:企業の戦略・SWOT・財務情報
    Kesko Corporation - Strategy, SWOT and Corporate Finance Report Summary Kesko Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Itamar Medical Ltd (ITMR):企業の財務・戦略的SWOT分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, manufactures, and markets non-invasive medical devices for the diagnosis of cardiology disease and sleep related breathing disorders. The company develops products using its proprietary peripheral arterial tonomet …
  • Oriental Land Co., Ltd.:企業の戦略・SWOT・財務情報
    Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Albireo Pharma Inc (ALBO)-製薬・医療分野:企業M&A・提携分析
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., is a specialty biopharmaceutical company that focuses on the development and commercialization of innovative bile acid modulators for the treatment of orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and d …
  • Energy XXI Gulf Coast Inc (EXXIQ):企業の財務・戦略的SWOT分析
    Summary Energy XXI Gulf Coast Inc (Energy XXI) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include West Delta, South Timbalier, South Pass, Main Pass, and Ship Shoal. Its West Delta property is located 28 miles offshore of Grand Isle, Louis …
  • Kuwait Petroleum International Ltd:企業の戦略的SWOT分析
    Kuwait Petroleum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Shionogi & Co., Ltd.:企業のM&A・事業提携・投資動向
    Shionogi & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shionogi & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Genera Biosystems Ltd (GBI)-医療機器分野:企業M&A・提携分析
    Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pat …
  • The AES Corporation (AES)-エネルギー分野:企業M&A・提携分析
    Summary The AES Corporation (AES) is a diversified power company, which owns and operates power generating facilities. The company generates electricity through diverse fuel sources such as gas, fuel oil and coal; and renewable sources such as wind, hydro, biomass and solar. It sells the electricity …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Empresa Electrica Corani SA (COR1U):電力:M&Aディール及び事業提携情報
    Summary Empresa Electrica Corani SA (Empresa Electrica), a subsidiary of Empresa Nacional de Electricidad Bolivia, is a renewable energy company that develops and operates hydroelectric power plants and wind farms. The company offers operation and maintenance, project development, and technical serv …
  • Clark Construction Group LLC:企業の戦略的SWOT分析
    Clark Construction Group LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Pharmicell Co Ltd (005690):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmicell Co Ltd (Pharmicell), formerly Yuhaw Trade Co Ltd is a biopharmaceutical company that discovers, develops, and commercializes stem cell drugs. The company offers pipeline products such as Cellgram_AMI a heart disease drug, Cellgram_Lung a pulmonary disease drug, and Cellgram_IS and …
  • Eckoh PLC (ECK):企業の財務・戦略的SWOT分析
    Summary Eckoh PLC (Eckoh) is a technology service provider that offers secure payment products and customer service solutions. The company provides agent assisted payments, IVR payments, mobile and web payments and GPDR. Its agent assisted payments include DTMF Masking, audio tokenization, alternati …
  • Ferrellgas Partners, L.P.:企業の戦略・SWOT・財務情報
    Ferrellgas Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Ferrellgas Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Depuy Synthes Companies:企業の戦略・SWOT・財務分析
    Depuy Synthes Companies - Strategy, SWOT and Corporate Finance Report Summary Depuy Synthes Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆